Fig. 3From: Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancerIn silico analysis using Alamut software. ATM variants identified in PBMCs derived from two familial breast cancer patients (BC patient#1 and #2) and one breast-thyorid cancer patient (BTC patient#7) lead to an increased affinity and/or appearance of a de novo sites for SR proteinsBack to article page